Medanta Global Health Limited (NSE: Medanta, BSE: 543654) has reinforced its leadership in India’s private healthcare sector with the inauguration of a 550-bed super-specialty hospital in Noida. Operational since September 2025 with 226 beds, 81 ICU beds, and five operating theatres, the hospital has onboarded 151 doctors and deployed advanced medical technologies, reflecting Medanta’s strategic focus on delivering high-quality care and effective hospital management across its network.
For Q2 FY2026, Medanta reported consolidated total income of INR 11,189 million, up 14.8% year-on-year, with net profit rising 21.1% to INR 1,584 million. EBITDA excluding Noida grew 13.7% to INR 2,804 million. Mature hospitals contributed INR 7,200 million in revenue, while developing hospitals excluding Noida grew 28.3%. International patient revenue increased 48.5% to INR 762 million, and OPD pharmacy revenue rose 23.9% to INR 456 million, underscoring the group’s strong operational and management capabilities.
Medanta is evaluating strategic expansions to provide advanced tertiary care to northeastern communities. By exploring potential sites and partnerships, the company aims to enhance healthcare access, optimize resource utilization, and implement best-in-class management practices in the region. Other highlights include bed expansions in Patna and Lucknow, and the upcoming 500–750 bed hospital in Mumbai, demonstrating Medanta’s robust growth strategy and leadership-driven operational excellence across India.
